7[4]Kusaka M, Sudo K, Matsutani E,et al. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470(AGM-1470). Br J Cancer, 1994, 69:212
8[5]Abe J, Zhou W, Takwa N,et al. A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits action of cyclin-dependent kinase and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells. Cancer Res, 1994, 54:3407
9[6]Yanase T, Tamura M, Fujita K,et al. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res, 1993, 53:2566
10[7]Blood CH, Zetter BR. Tumor interaction with vasculature: Angiogenesis and tumor metastasis (Review). Biochem Biophys Acta, 1990, 1032:89
3Dao-Xiong Lei~(1,2) Cheng-Hong Peng~1 Shu-You Peng~1 Xian-Chuan Jiang~1 Yu-Lian Wu~1 Hong-Wei Shen~1 1 Department of Surgery,Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310009,Zhejiang Province,China2 Department of Surgery,Zhongnan Hospital,Wuhan University School of Medicine,Wuhan 430071,Hubei Province,China.Safe upper limit of intermittent hepatic inflow occlusion for liver resection in cirrhotic rats[J].World Journal of Gastroenterology,2001,7(5):713-717. 被引量：8
4Zheng-Xu Wang~1 Gui-Fang Hu~1 Hong-Yang Wang~2 Meng-Chao Wu~2 1 Department of General Surgery,Chinese PEA General Hospital of Lanzhou Military Command,Lanzhou 730050,Gansu Province,China2 Eastern Hepatobilliary Surgical Hospital,Second Military Medical University,Shanghai 200438,China.Expression of liver cancer associated gene HCCA3[J].World Journal of Gastroenterology,2001,7(6):821-825. 被引量：9
7Wan-Ping Chen, Xin He, Qi-Fa Ye and Ke Li Institute of Organ Transplantation, Third Xiangya Hospital, Xiangya Medical College, Central South University, Changsha 410013, China, and Institute of Clinical Pharmacology, Xiangya Medical College, Central South University, Changsha 410078, China.Implantation of a drug delivery system during surgery for patients with primary hepatocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2006,5(3):391-395. 被引量：2
